In this episode of Denatured, you’ll hear Philip Jacob Rosenfeld, professor of Ophthalmology at the University of Miami Health System and Bascom Palmer Eye Institute, and Wesley Jackson, chief science officer at Valitor. We talk about the eye condition call wet age-related macular degeneration (AMD), the limits of anti‑VEGF therapy and the push for true durability to change a patient’s life.

Host

Jennifer C. Smith-Parker, Director of Insights, BioSpace

Guests

Philip Jacob Rosenfeld, Professor of Ophthalmology, University of Miami Health System, Bascom Palmer Eye Institute

Wesley Jackson, Chief Science Officer, Valitor  

Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.